Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group M - Magnesium Sulfate: Injection Levobupivacaine 0.5% 25 ml + Injection Magnesium Sulfate 250 mg diluted in 5 ml normal saline (NS) given by supraclavicular approach under USG gui
Sponsors
BJMedical College and Civil Hospital Ahmedabad
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age: 18-60 years. 2 Gender: Both. 3 ASA physical status I, II. 4 Patient undergoing upper limb surgeries below shoulder.
Exclusion criteria
Exclusion criteria: 1 ASA physical status III, IV, V. 2 Unwilling patient. 3 Having head injury 4 Patient having distal neuro-vascular deficit 5 Had a history of hypersensitivity to the any of the study drug. 6 Known allergy to LA 7 Patient already received either fentanyl or magnesium sulfate. 8 Pregnant patient. 9 H/o cardiac, hepatic, or renal disease. 10 On treatment with calcium channel blockers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess sensory blockade and motor blockadeTimepoint: To assess sensory blockade and motor blockade at every 2 minutes for 10 minutes then every 5 minutes till 30 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess analgesia profile by measuring 1 Duration of postoperative analgesia 2 Number of rescue analgesia required in first 24 hours.Timepoint: Postoperatively at 30 minutes & then every two hours upto four hours & then every four till 24 hours;To observe hemodynamic parameters like heart rate, MAP, SpO2Timepoint: Every five minutes upto 15 minutes then every 15 minutes till surgery lasts.;To observe complications, if anyTimepoint: Postoperatively upto 24 hours. | — |
Countries
India
Contacts
Public ContactDr Riya Solanki
B.J.Medical College, Ahmedabad
Outcome results
None listed